scholarly journals Inflammation-related indicators to distinguish between gastric stromal tumors and leiomyomas: A retrospective study

2022 ◽  
Vol 10 (2) ◽  
pp. 458-468
Author(s):  
Yu-Hao Zhai ◽  
Zhi Zheng ◽  
Wei Deng ◽  
Jie Yin ◽  
Zhi-Gang Bai ◽  
...  
2017 ◽  
Vol 24 (6) ◽  
pp. 582-589 ◽  
Author(s):  
Guanglin Qiu ◽  
Jing Wang ◽  
Xiangming Che ◽  
Shicai He ◽  
Chao Wei ◽  
...  

2015 ◽  
Vol 51 ◽  
pp. S427
Author(s):  
R. Tielen ◽  
M. Seesing ◽  
R. Van Hillegersberg ◽  
C. Verhoef ◽  
F. Van Coevorden ◽  
...  

2017 ◽  
Vol 27 (2) ◽  
pp. 110-114 ◽  
Author(s):  
Jiang-Long Huang ◽  
Zong-Heng Zheng ◽  
Hong-Bo Wei ◽  
Tu-Feng Chen ◽  
Jian-Pei Liu ◽  
...  

2013 ◽  
Vol 6 (1) ◽  
pp. 87 ◽  
Author(s):  
Saroona Haroon ◽  
Aleena Zia ◽  
Romana Idrees ◽  
Aisha Memon ◽  
Saira Fatima ◽  
...  

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e23512-e23512
Author(s):  
Elise Nassif ◽  
Louise De Forceville ◽  
Arthur Geraud ◽  
Justine Gantzer ◽  
Charles Honoré ◽  
...  

Sarcoma ◽  
2009 ◽  
Vol 2009 ◽  
pp. 1-6 ◽  
Author(s):  
A. W. Oosten ◽  
C. Seynaeve ◽  
P. I. M. Schmitz ◽  
M. A. den Bakker ◽  
J. Verweij ◽  
...  

Although leiomyosarcomas (LMSs) form the largest subgroup of soft tissue sarcomas (STSs), the efficacy of chemotherapy in this group is largely unclear, partly because older studies are contaminated with gastrointestinal stromal tumors (GISTs). In this retrospective study we investigated the outcome of first line chemotherapy in 65 patients with unresectable or metastatic LMS. The overall response rate (ORR) was 18%; and the median progression-free (PFS) and overall survival (OS) were 3.8 and 9.7 months respectively. No statistically significant differences in outcomes for uterine and non-uterine LMS were found. In non-uterine LMS, however, the PFS and OS seemed to be longer for females than for males, potentially negatively affecting outcomes in this group. If our observations are confirmed in other series, they would suggest that studies performed in STS patients should not only stratify for histological subtype but also for uterine versus non-uterine LMS and for gender.


2021 ◽  
Vol 04 (01) ◽  
pp. 014-023
Author(s):  
Geena Benjamin ◽  
Thara Pratap ◽  
Mangalanandan Sreenivasan ◽  
Dhanya Jacob ◽  
Agnes Thomas ◽  
...  

Abstract Background Gastrointestinal stromal tumors (GISTs) are the most common gastrointestinal mesenchymal neoplasms which can arise from any part of the gastrointestinal tract (GIT) or an extraintestinal location. Size and the organ of origin are the major imaging inputs expected from the radiologist. However, it is worthwhile to find out which imaging characteristics on MDCT correlate with risk stratification. This knowledge would help the clinician in treatment planning and prognostication. The aim of this retrospective study is to evaluate the various MDCT imaging characteristics of GISTs and find out which parameters have significant association with risk and subsequent development of metastasis on follow-up whenever it was possible. Materials and Methods This is a retrospective study conducted on 45 histopathologically proven cases of GIST from two institutions by searching from the digital archives. The following imaging parameters were analyzed: maximum size in any plane, organ of origin, shape (round, ovoid or irregular), margin (well-defined or ill-defined), surface (smooth or lobulated), percentage of necrosis, growth pattern, enhancement characteristics–both intensity (mild, moderate or significant) and pattern (homogenous vs. heterogenous), calcification, infiltration into adjacent organs, and presence of metastasis at presentation or on follow-up. Results CT morphological parameters of significance in risk stratification as per our study include tumor necrosis, predominant cystic change, irregular and lobulated shape/surface characteristics, and adjacent organ infiltration.The parameters which were associated with development of metastasis were size > 5 cm, necrosis > 30%, and the presence of adjacent organ infiltration. Conclusion The radiologist has an important role in ascertaining the size of tumor as well as the organ of origin accurately to guide the clinician in risk calculation and subsequent prognostication. In addition, certain CT characteristics mentioned above, namely, tumor size, significant necrosis/cystic changes, irregular/lobulated contour, and invasion of adjacent organs, help in risk stratification and in predicting metastasis/poor prognosis.


Sign in / Sign up

Export Citation Format

Share Document